In participants with baseline HIV-@ RNA more than @ copies/ml ( n = @ ) , RPV/FTC/TDF demonstrated noninferior efficacy compared with EFV/FTC/TDF ( @ vs. @ % , respectively , difference -@ % , @ % CI -@ to @ % ) .